Cargando…
COVID-19 Seroprevalence in Canada Modelling Waning and Boosting COVID-19 Immunity in Canada a Canadian Immunization Research Network Study
COVID-19 seroprevalence changes over time, with infection, vaccination, and waning immunity. Seroprevalence estimates are needed to determine when increased COVID-19 vaccination coverage is needed, and when booster doses should be considered, to reduce the spread and disease severity of COVID-19 inf...
Autores principales: | Dick, David W., Childs, Lauren, Feng, Zhilan, Li, Jing, Röst, Gergely, Buckeridge, David L., Ogden, Nick H., Heffernan, Jane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779812/ https://www.ncbi.nlm.nih.gov/pubmed/35062678 http://dx.doi.org/10.3390/vaccines10010017 |
Ejemplares similares
-
Modeling waning and boosting of COVID-19 in Canada with vaccination
por: Childs, Lauren, et al.
Publicado: (2022) -
Modeling the waning and boosting of immunity from infection or vaccination()
por: Carlsson, Rose-Marie, et al.
Publicado: (2020) -
Waning and boosting: on the dynamics of immune status
por: Diekmann, O., et al.
Publicado: (2018) -
2454. Pertussis Vaccine Effectiveness and Waning Immunity in Alberta, Canada: 2004–2015
por: Bell, Christopher A, et al.
Publicado: (2018) -
Tuberculosis and COVID-19 in Canada
por: Long, Richard, et al.
Publicado: (2020)